Join the Macular Degeneration group to help and get support from people like you.
Macular Degeneration News
Related terms: Blurry Vision
Intraocular Inflammation More Common With Aflibercept Injections in Real-World Setting
FRIDAY, May 9, 2025 – The incidence of mild intraocular inflammation (IOI) in the real world occurs more frequently after intravitreal injection of aflibercept than in clinical trials, according to...
Why Treatments Can Fail Folks With 'Wet' Macular Degeneration -- and What Might Really Work
TUESDAY, Nov. 5, 2024 – Current treatments sometimes fail to help people with “wet” age-related macular degeneration – and researchers now think they know why. Wet AMD is caused by an overgrowth of ...
AAO: Prior Intravitreal Injections Increase Risk for Cataract Surgery Complications
WEDNESDAY, Oct. 23, 2024 – A history of multiple past intravitreal injections (IVIs) poses a risk for certain future cataract surgery complications, according to a study presented at the annual ...
Light Therapy Might Help Ease 'Dry' Form of Macular Degeneration
TUESDAY, Oct. 22, 2024 – Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says. The therapy, called photobiomodulation or “red l...
Age-Related Macular Degeneration Tied to Heightened Risk for Rheumatoid Arthritis
WEDNESDAY, Oct. 9, 2024 – Age-related macular degeneration (AMD) is associated with a higher risk for rheumatoid arthritis (RA), according to a study published online Sept. 9 in Scientific Reports. ...
Stem Cell Therapy Might Repair Vision-Robbing Holes in Retinas
THURSDAY, Oct. 3, 2024 – Japanese researchers have successfully used a transplant of human stem cells to close a hole in a key part of a monkey's retina. They say the achievement could pave the way...
Scientists Get Closer to Stopping Macular Degeneration
WEDNESDAY, Oct. 2, 2024 – Scientists say they've discovered a protein that seems crucial to the onset of age-related macular degeneration (AMD), a common cause of blindness in older people. The...
FDA Approves Pavblu (aflibercept-ayyh), a Biosimilar to Eylea
August 23, 2024 – The U.S. Food and Drug Administration (FDA) has announced the approval of Pavblu (aflibercept-ayyh) 2 mg injection (single-dose prefilled syringe and single-dose vial) for i...
Socioeconomic Factors Increase Risk for Age-Related Macular Degeneration
WEDNESDAY, Sept. 25, 2024 – Socioeconomic factors are linked to an increased risk for age-related macular degeneration (AMD), according to a study published online July 1 in Health Data Science. ...
Healthy Tips to Protect Your Eyes' Retinas as You Age
SUNDAY, Sept. 8, 2024 – Getting older tends to go hand in hand with failing vision, but eye experts say there are things you can do to preserve your sight as you age. The risk of age-related macular...
FDA Approves Enzeevu (aflibercept-abzv), a Biosimilar to Eylea
Basel, August 12, 2024 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) has approved Enzeevu (...
Daily Supplements May Slow 'Dry' Form of Macular Degeneration
MONDAY, July 22, 2024 – Daily supplements can slow loss of vision related to late-stage “dry” age-related macular degeneration (AMD), a new study finds. The rate of dry AMD progression into a key eye...
Micronutrient Supplementation Slows Geographic Atrophy Progression
FRIDAY, July 19, 2024 – Oral micronutrient supplementation slows geographic atrophy (GA) progression in age-related macular degeneration (AMD), according to a study published online July 16 in...
Genentech to Reintroduce Susvimo for People With Wet Age-Related Macular Degeneration (AMD)
South San Francisco, CA – July 8, 2024 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the reintroduction of Susvimo® (ranibizumab injection) 100 mg/mL for ...
Robotic Procedure Helps Treat Macular Degeneration
THURSDAY, June 12, 2024 – Robot-guided radiation therapy can improve treatment for age-related macular degeneration, the leading cause of vision loss and blindness among American seniors, a new...